Cargando…

Cognitive Impairment in Type 2 Diabetes Mellitus

Objective To determine the incidence of cognitive impairment established on the mini-mental state assessment in type 2 diabetic patients presenting at Holy Family Hospital, Rawalpindi. Materials and methods This cross-sectional descriptive study was carried out from June 2019 to December 2019. Indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Aimen, Ahmed, Mubariz, Mansoor, Sarah, Ambreen, Saima, Usman, Basil, Shehryar, Malik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925983/
https://www.ncbi.nlm.nih.gov/pubmed/35308758
http://dx.doi.org/10.7759/cureus.22193
_version_ 1784670141408083968
author Malik, Aimen
Ahmed, Mubariz
Mansoor, Sarah
Ambreen, Saima
Usman, Basil
Shehryar, Malik
author_facet Malik, Aimen
Ahmed, Mubariz
Mansoor, Sarah
Ambreen, Saima
Usman, Basil
Shehryar, Malik
author_sort Malik, Aimen
collection PubMed
description Objective To determine the incidence of cognitive impairment established on the mini-mental state assessment in type 2 diabetic patients presenting at Holy Family Hospital, Rawalpindi. Materials and methods This cross-sectional descriptive study was carried out from June 2019 to December 2019. Individuals with a diagnosis of type 2 diabetes mellitus were included, and detailed history, physical examination, and biochemical variables were noted. They were assessed through Mini-Mental State Examination (MMSE) (Urdu translation) to look for the primary outcome variable, i.e., cognitive impairment. All patients with type 2 diabetes mellitus diagnosed at least one year back, irrespective of gender, were included in this investigation. Patients with a previous history of head injury, epilepsy, stroke, those on an antidepressant or antipsychotic medications, those with deranged renal function tests, and those already diagnosed with dementia were excluded from the study. Results Three hundred thirty-two patients meeting the inclusion criteria were included in the study. The mean ± standard deviation age of the study population was 65.32 ± 11.33 years, with maximum age being 80 years and the minimum being 50 years. Two hundred patients (60.24%) were below 65 years of age, and 132 patients (39.76%) were 65 years of age or above. Two hundred sixteen (65.06%) were males, and 116 (34.96%) were females. The mean duration of diabetes mellitus (DM) was 10.17 ± 4.81. The mean MMSE score was 22.69 ± 5.26. Out of 332 patients, 81 (24.4%) patients had cognitive impairment. Patients who were 65 or older had a significantly higher proportion of cognitive impairment, compared to those below 65 years of age (p-value = 0.0214). There was no significant difference in the proportion of cognitively impaired patients between males and females (p-value = 0.2497). Similarly, there was no significant difference between those who were diagnosed with type 2 diabetes for 10 years or more and those who were diagnosed less than 10 years ago (p-value = 0.3791). Conclusion Cognitive impairment is common in individuals having type 2 diabetes mellitus. It is also associated with the increasing age of diabetic patients. However, cognitive impairment in type 2 diabetes mellitus is not associated with gender. In addition, there is no significant difference in cognitive impairment between the patients who were diagnosed with diabetes more than 10 years ago and those who had it diagnosed less than 10 years ago.
format Online
Article
Text
id pubmed-8925983
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89259832022-03-18 Cognitive Impairment in Type 2 Diabetes Mellitus Malik, Aimen Ahmed, Mubariz Mansoor, Sarah Ambreen, Saima Usman, Basil Shehryar, Malik Cureus Endocrinology/Diabetes/Metabolism Objective To determine the incidence of cognitive impairment established on the mini-mental state assessment in type 2 diabetic patients presenting at Holy Family Hospital, Rawalpindi. Materials and methods This cross-sectional descriptive study was carried out from June 2019 to December 2019. Individuals with a diagnosis of type 2 diabetes mellitus were included, and detailed history, physical examination, and biochemical variables were noted. They were assessed through Mini-Mental State Examination (MMSE) (Urdu translation) to look for the primary outcome variable, i.e., cognitive impairment. All patients with type 2 diabetes mellitus diagnosed at least one year back, irrespective of gender, were included in this investigation. Patients with a previous history of head injury, epilepsy, stroke, those on an antidepressant or antipsychotic medications, those with deranged renal function tests, and those already diagnosed with dementia were excluded from the study. Results Three hundred thirty-two patients meeting the inclusion criteria were included in the study. The mean ± standard deviation age of the study population was 65.32 ± 11.33 years, with maximum age being 80 years and the minimum being 50 years. Two hundred patients (60.24%) were below 65 years of age, and 132 patients (39.76%) were 65 years of age or above. Two hundred sixteen (65.06%) were males, and 116 (34.96%) were females. The mean duration of diabetes mellitus (DM) was 10.17 ± 4.81. The mean MMSE score was 22.69 ± 5.26. Out of 332 patients, 81 (24.4%) patients had cognitive impairment. Patients who were 65 or older had a significantly higher proportion of cognitive impairment, compared to those below 65 years of age (p-value = 0.0214). There was no significant difference in the proportion of cognitively impaired patients between males and females (p-value = 0.2497). Similarly, there was no significant difference between those who were diagnosed with type 2 diabetes for 10 years or more and those who were diagnosed less than 10 years ago (p-value = 0.3791). Conclusion Cognitive impairment is common in individuals having type 2 diabetes mellitus. It is also associated with the increasing age of diabetic patients. However, cognitive impairment in type 2 diabetes mellitus is not associated with gender. In addition, there is no significant difference in cognitive impairment between the patients who were diagnosed with diabetes more than 10 years ago and those who had it diagnosed less than 10 years ago. Cureus 2022-02-14 /pmc/articles/PMC8925983/ /pubmed/35308758 http://dx.doi.org/10.7759/cureus.22193 Text en Copyright © 2022, Malik et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Malik, Aimen
Ahmed, Mubariz
Mansoor, Sarah
Ambreen, Saima
Usman, Basil
Shehryar, Malik
Cognitive Impairment in Type 2 Diabetes Mellitus
title Cognitive Impairment in Type 2 Diabetes Mellitus
title_full Cognitive Impairment in Type 2 Diabetes Mellitus
title_fullStr Cognitive Impairment in Type 2 Diabetes Mellitus
title_full_unstemmed Cognitive Impairment in Type 2 Diabetes Mellitus
title_short Cognitive Impairment in Type 2 Diabetes Mellitus
title_sort cognitive impairment in type 2 diabetes mellitus
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925983/
https://www.ncbi.nlm.nih.gov/pubmed/35308758
http://dx.doi.org/10.7759/cureus.22193
work_keys_str_mv AT malikaimen cognitiveimpairmentintype2diabetesmellitus
AT ahmedmubariz cognitiveimpairmentintype2diabetesmellitus
AT mansoorsarah cognitiveimpairmentintype2diabetesmellitus
AT ambreensaima cognitiveimpairmentintype2diabetesmellitus
AT usmanbasil cognitiveimpairmentintype2diabetesmellitus
AT shehryarmalik cognitiveimpairmentintype2diabetesmellitus